On February 28, 2023 NuCana plc (Nasdaq: NCNA) reported that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in two upcoming investor conferences (Press release, Nucana BioPharmaceuticals, FEB 28, 2023, View Source [SID1234627869]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Cowen’s 43rd Annual Healthcare Conference
Presentation Date: Tuesday, March 7, 2023
Presentation Time: 10:30 AM ET

Event: Oppenheimer’s 33rd Annual Healthcare Conference
Presentation Date: Tuesday, March 14, 2023
Presentation Time: 12:40 PM ET

The presentations at both conferences will be webcast live and available for replay under "Events & Presentations" in the Investors section of the Company’s website at www.nucana.com.